The cost effectiveness of varenicline for smoking cessation.

Managed care interface

Volumn 20, Issue 10, 2007, Pages 18-25

  Halpern, Michael T ^a   Dirani, Riad ^a   Schmier, Jordana K ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAZEPINE DERIVATIVE; QUINOXALINE DERIVATIVE; VARENICLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; FEMALE; HEALTH SURVEY; HUMAN; MALE; MEDICAID; MIDDLE AGED; SMOKING CESSATION; STATISTICAL MODEL; UNITED STATES;

ADOLESCENT; ADULT; AGED; BENZAZEPINES; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MEDICAID; MIDDLE AGED; MODELS, ECONOMETRIC; QUINOXALINES; SMOKING CESSATION; UNITED STATES;

EID: 44049095359     PISSN: 10965645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)